Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway
Open Access
- 29 October 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 125 (Pt A) , 111125
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Province Postdoctoral Science Foundation
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
This publication has 43 references indexed in Scilit:
- Double hit lymphoma: the MD Anderson Cancer Center clinical experienceBritish Journal of Haematology, 2014
- Naive T cells: The crux of cellular immune aging?Experimental Gerontology, 2014
- Global Regulation of Nucleotide Biosynthetic Genes by c-MycPLOS ONE, 2008
- Prognostic significance of drug-regulated genes in high-grade osteosarcomaLaboratory Investigation, 2007
- Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discoveryMedicinal Research Reviews, 2007
- ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2Biochemistry and Cell Biology, 2006
- Differentiation of Human Prostate Cancer PC-3 Cells Induced by Inhibitors of Inosine 5′-Monophosphate DehydrogenaseCancer Research, 2004
- Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205)Life Sciences, 1994
- Chromosomal Localization and Structure of the Human Type II IMP Dehydrogenase Gene (IMPDH2)Genomics, 1993
- IMP dehydrogenase, an enzyme linked with proliferation and malignancyNature, 1975